| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.8 |